NEW YORK (360Dx) — Opko Health's BioReference Laboratories (BRL) said on Thursday that it has been named a preferred laboratory by Horizon Blue Cross Blue Shield of New Jersey.
Elmwood Park, New Jersey-based BRL — which is already an in-network lab with Horizon BCBS — said that the preferred lab status includes its GeneDx subsidiary. As a result, Horizon BCBS' more than 3.8 million members in New York, New Jersey, and Pennsylvania will have access to both BRL and GeneDx's lab testing menus and network of regional patient service centers.
The agreement becomes effective Jan. 1, 2019 and includes all non-managed care plans in the Horizon BCBS network.
Earlier Thursday, Horizon BCBS announced that it had renewed its lab services relationship with Laboratory Corporation of America and added Quest Diagnostics as an in-network provider.